Figure 2.
(A) Utilization of allo-HCT for cHL in the US. (B) Overall survival of patients undergoing allo-HCT in the US from 1990 to 2020. Based on CIBMTR registry data.

(A) Utilization of allo-HCT for cHL in the US. (B) Overall survival of patients undergoing allo-HCT in the US from 1990 to 2020. Based on CIBMTR registry data.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal